|
 
 |
| LETTER TO EDITOR |
|
| Year : 2014 | Volume
: 3
| Issue : 4 | Page : 254-255 |
|
Gastric gastrointestinal stromal tumor and neuroendocrine pancreatic tumor: Always neurofibromatosis?
Lídia Roque Ramos1, Pedro Pinto Marques1, Joana Nogueira2, Maria José Brito2
1 Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal
2 Department of Pathology, Hospital Garcia de Orta, Almada, Portugal
| Date of Web Publication | 12-Nov-2014 |
Correspondence Address:
Lídia Roque Ramos
Department of Gastroenterology, Hospital Garcia de Orta, Almada
Portugal
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2303-9027.144552
How to cite this article:
Ramos LR, Marques PP, Nogueira J, Brito MJ. Gastric gastrointestinal stromal tumor and neuroendocrine pancreatic tumor: Always neurofibromatosis?. Endosc Ultrasound 2014;3:254-5 |
How to cite this URL:
Ramos LR, Marques PP, Nogueira J, Brito MJ. Gastric gastrointestinal stromal tumor and neuroendocrine pancreatic tumor: Always neurofibromatosis?. Endosc Ultrasound [serial online] 2014 [cited 2021 Mar 3];3:254-5. Available from: http://www.eusjournal.com/text.asp?2014/3/4/254/144552 |
Dear Editor,
A 52-year-old female patient presented to the emergency department with hematemesis, hypotension and tachycardia. She had a history of hypertension and denied other illnesses. The gastroscopy revealed an ulcerated 35 mm subepithelial lesion in the upper gastric corpus. The computed tomography excluded suspicious lymph nodes and metastasis. On endoscopic ultrasound (EUS) (UCT 10-140 AL5; Olympus) the lesion was hypoechoic and heterogeneous with ill-defined borders [Figure 1]a and originated in the fourth layer. Incidentally, an isoechoic 5.8 mm Doppler negative nodule was identified in the pancreatic tail [Figure 1]b. Fine needle aspiration was taken with a 22C needle from the gastric lesion and with a 25-gauge needle from the pancreatic nodule. Cell block cytology was consistent with a gastric stromal tumor [Figure 2]a-c and a neuroendocrine pancreatic tumor [Figure 3]a and b. The patient was readmitted 6 days after discharge with recurrent bleeding and hemodynamic instability and underwent an atypical gastrectomy. At 2 years follow-up there is no evidence of gastric stromal tumor recurrence nor pancreatic neuroendocrine tumor size increase or metastasis. | Figure 1. Linear endoscopic ultrasound depicted: (a) 35 mm hypoechoic heterogeneous mass in the upper gastric corpus. Layer or origin muscular propria; (b) incidental 5.8 mm isoechoic nodule in pancreatic tail
Click here to view |
 | Figure 2. Cytology examination of the gastric mass showing: (a) Spindle cells with elongated nuclei and eosinophilic cytoplasm (H and E stain; ×400); (b) positive staining for CD117; (c) negative stain for S100; (d) negative stain for smooth muscle actin
Click here to view |
 | Figure 3. Cytology examination of the pancreatic nodule depicting: (a) Loose aggregates of cells with round and uniform nuclei with fine chromatin and eosinophilic cytoplasm (H and E stain; ×400); (b) positive staining for synaptophysin; (c) positive stain for cromogranine A
Click here to view |
Gastrointestinal stromal tumors (GISTs) are rare, representing <1% of all gastrointestinal tumors. Interestingly, 13% of sporadic GISTs occur with a second malignancy, more commonly (47%) gastrointestinal carcinomas, but also neuroendocrine tumors of any location in 3% of cases. [1] In the literature, there are four cases of pancreatic neuroendocrine tumors coexisting with GISTs in patients without type 1 neurofibromatosis (NF-1). [2],[3],[4],[5] Interestingly, in NF-1 patients in whom these tumors are frequent, there are only 9 cases reporting this association. [3] The question raised by the present case is whether this association is a coincidental finding or are we actually overlooking the pancreas when assessing GIST patients. A systematic evaluation of the pancreas, when EUS is performed in this setting, could help clarify this question.
| References | |  |
| 1. | Agaimy A, Wünsch PH, Sobin LH, et al. Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Semin Diagn Pathol 2006;23:120-9.  |
| 2. | Kövér E, Faluhelyi Z, Bogner B, et al. Dual tumours in the GI tract: Synchronous and metachronous stromal (GIST) and epithelial/neuroendocrine neoplasms. Magy Onkol 2004;48:315-21. |
| 3. | Alabraba E, Bramhall S, O'Sullivan B, et al. Pancreatic insulinoma co-existing with gastric GIST in the absence of neurofibromatosis-1. World J Surg Oncol 2009;7:18. |
| 4. | Haugvik SP, Røsok BI, Edwin B, et al. Concomitant nonfunctional pancreatic neuroendocrine tumor and gastric GIST in a patient without neurofibromatosis type 1. J Gastrointest Cancer 2011; 15. |
| 5. | Tavares AB, Viveiros FA, Cidade CN, et al. Gastric GIST with synchronous neuroendocrine tumour of the pancreas in a patient without neurofibromatosis type 1. BMJ Case Rep 2012;2012. |
[Figure 1], [Figure 2], [Figure 3]
|
Search Pubmed for